Skip to content

Clinical trials

Non-alcoholic Fatty Liver Disease trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Country / region: Taiwan Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20121
20131
20163
20176
20181
20192
20206
20217
20226
20236
20243
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting9
Terminated9
Unknown status6
Active, not recruiting3
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital6
Chang Gung Memorial Hospital3
Merck Sharp & Dohme LLC3
Novartis Pharmaceuticals3
Sinew Pharma Inc.3
89bio, Inc.2
AstraZeneca2
Gilead Sciences2
GlaxoSmithKline2
Novo Nordisk A/S2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease48
Fatty Liver7
Liver Diseases5
Liver Cirrhosis4
Obesity4
Metabolic Syndrome3
Overweight3
Digestive System Diseases2
Fibrosis2
Hepatitis B2

Trials

Showing 26 to 48 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.